SEC Form 4 reporting owner

Benevich Eric

Benevich Eric has filed 17 Form 4 transactions reported between January 31, 2026 and September 11, 2026, as Chief Commercial Officer of NEUROCRINE BIOSCIENCES INC and a reporting owner of aTYR PHARMA INC.

Name as filed: BENEVICH ERIC

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$333K

1 lines

Companies

with Form 4 filings

Latest transaction

Sep 11, 2026

transaction date

Roles and reported holdings

NBIXNEUROCRINE BIOSCIENCES INC
Jan 31, 2026 – Sep 11, 2026
Chief Commercial Officer
Held directly67,297 sh as of Sep 11, 2026 · Form 4
24 months: $333K sold
ATYRaTYR PHARMA INC
May 11, 2026
Reporting owner
No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 17 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Sep 11, 2026	NBIXChief Commercial Officer	Shares withheld for tax or exercise priceCode F · direct	3,386	$156.22	$529K@ $156.22	67,297	Form 4
Sep 11, 2026	NBIXChief Commercial Officer	Grant or awardCode A · direct	6,275	—	—	70,683	Form 4
Sep 9, 2026	NBIXChief Commercial Officer	Open-market saleCode S · direct	2,154	$154.61	$333K@ $154.61	64,408	Form 4
Sep 9, 2026	NBIXChief Commercial Officer	Option exerciseCode M · direct	3,194	$43.24	$138K@ $43.24	66,562	Form 4
May 11, 2026	ATYR	Grant or awardCode A · direct	50,000	—	—	50,000	Form 4
Feb 13, 2026	NBIXChief Commercial Officer	Grant or awardCode A · direct	6,365	—	—	6,365	Form 4
Feb 13, 2026	NBIXChief Commercial Officer	Grant or awardCode A · direct	36,287	—	—	36,287	Form 4
Feb 13, 2026	NBIXChief Commercial Officer	Shares withheld for tax or exercise priceCode F · direct	8,963	$124.12	$1.1M@ $124.12	63,190	Form 4
Feb 13, 2026	NBIXChief Commercial Officer	Grant or awardCode A · direct	16,613	—	—	72,153	Form 4
Feb 13, 2026	NBIXChief Commercial Officer	Shares withheld for tax or exercise priceCode F · direct	1,124	$124.12	$140K@ $124.12	55,540	Form 4
Feb 13, 2026	NBIXChief Commercial Officer	Option exerciseCode M · direct	2,083	—	—	56,664	Form 4
Feb 13, 2026	NBIXChief Commercial Officer	Shares withheld for tax or exercise priceCode F · direct	1,058	$124.12	$131K@ $124.12	54,581	Form 4
Feb 13, 2026	NBIXChief Commercial Officer	Option exerciseCode M · direct	1,961	—	—	55,639	Form 4
Feb 12, 2026	NBIXChief Commercial Officer	Shares withheld for tax or exercise priceCode F · direct	1,082	$123.10	$133K@ $123.10	53,678	Form 4
Feb 12, 2026	NBIXChief Commercial Officer	Option exerciseCode M · direct	2,005	—	—	54,760	Form 4
Jan 31, 2026	NBIXChief Commercial Officer	Shares withheld for tax or exercise priceCode F · direct	1,292	$136.06	$176K@ $136.06	52,755	Form 4
Jan 31, 2026	NBIXChief Commercial Officer	Option exerciseCode M · direct	2,294	—	—	54,047	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.